These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38534383)

  • 1. Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes Type I Interferon Signaling via Degradation of Histone Deacetylase 5.
    Gong Q; Ren S; Dou Y; Tadele BA; Hu T; Zhou L; Wang T; Yao K; Xu J; Yin X; Sun Y
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes TPL2-Mediated Activation of the IRF3/IFN-β Signaling Pathway to Facilitate the Virus Replication.
    Hao J; Shen C; Wei N; Yan M; Zhang X; Xu G; Zhang D; Hou J; Cao W; Jin Y; Zhang K; Zheng H; Liu X
    Front Immunol; 2020; 11():580334. PubMed ID: 33488582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication.
    Liu H; Xue Q; Yang F; Cao W; Liu P; Liu X; Zhu Z; Zheng H
    Autophagy; 2024 Jul; 20(7):1597-1615. PubMed ID: 38516932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular DNAJA3, a Novel VP1-Interacting Protein, Inhibits Foot-and-Mouth Disease Virus Replication by Inducing Lysosomal Degradation of VP1 and Attenuating Its Antagonistic Role in the Beta Interferon Signaling Pathway.
    Zhang W; Yang F; Zhu Z; Yang Y; Wang Z; Cao W; Dang W; Li L; Mao R; Liu Y; Tian H; Zhang K; Liu X; Ma J; Zheng H
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-Mouth Disease Virus Capsid Protein VP1 Interacts with Host Ribosomal Protein SA To Maintain Activation of the MAPK Signal Pathway and Promote Virus Replication.
    Zhu Z; Li W; Zhang X; Wang C; Gao L; Yang F; Cao W; Li K; Tian H; Liu X; Zhang K; Zheng H
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells.
    Li X; Wang J; Liu J; Li Z; Wang Y; Xue Y; Li X; Cao H; Zheng SJ
    Vet Microbiol; 2013 Sep; 166(1-2):35-46. PubMed ID: 23764275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foot-and-mouth disease virus structural protein VP3 interacts with HDAC8 and promotes its autophagic degradation to facilitate viral replication.
    Zhang H; Wang X; Qu M; Li Z; Yin X; Tang L; Liu X; Sun Y
    Autophagy; 2023 Nov; 19(11):2869-2883. PubMed ID: 37408174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
    Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
    Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
    J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation.
    Ekanayaka P; Lee SY; Herath TUB; Kim JH; Kim TH; Lee H; Chathuranga K; Chathuranga WAG; Park JH; Lee JS
    PLoS Pathog; 2020 Nov; 16(11):e1009057. PubMed ID: 33232374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
    Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
    J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of the DeISGylation Activity of Foot-and-Mouth Disease Virus Lpro Causes Attenuation
    Medina GN; Azzinaro P; Ramirez-Medina E; Gutkoska J; Fang Y; Diaz-San Segundo F; de Los Santos T
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-361 and miR-34a suppress foot-and-mouth disease virus proliferation by activating immune response signaling in PK-15 cells.
    Gao Y; Yong F; Yan M; Wei Y; Wu X
    Vet Microbiol; 2023 May; 280():109725. PubMed ID: 36996618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.
    Du Y; Bi J; Liu J; Liu X; Wu X; Jiang P; Yoo D; Zhang Y; Wu J; Wan R; Zhao X; Guo L; Sun W; Cong X; Chen L; Wang J
    J Virol; 2014 May; 88(9):4908-20. PubMed ID: 24554650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-and-Mouth Disease Virus 3B Protein Interacts with Pattern Recognition Receptor RIG-I to Block RIG-I-Mediated Immune Signaling and Inhibit Host Antiviral Response.
    Zhang X; Zhu Z; Wang C; Yang F; Cao W; Li P; Du X; Zhao F; Liu X; Zheng H
    J Immunol; 2020 Oct; 205(8):2207-2221. PubMed ID: 32917788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus L
    Sui C; Jiang D; Wu X; Liu S; Li F; Pan L; Cong X; Li J; Yoo D; Rock DL; Miller LC; Lee C; Du Y; Qi J
    J Virol; 2021 Jul; 95(15):e0036121. PubMed ID: 33980594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foot-and-mouth disease virus non-structural protein 2B negatively regulates the RLR-mediated IFN-β induction.
    Li M; Xin T; Gao X; Wu J; Wang X; Fang L; Sui X; Zhu H; Cui S; Guo X
    Biochem Biophys Res Commun; 2018 Sep; 504(1):238-244. PubMed ID: 30177393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.
    Wang D; Fang L; Li K; Zhong H; Fan J; Ouyang C; Zhang H; Duan E; Luo R; Zhang Z; Liu X; Chen H; Xiao S
    J Virol; 2012 Sep; 86(17):9311-22. PubMed ID: 22718831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication.
    Ma X; Zhang K; Luo Z; Nian X; Choudhury SKM; Zhu Z; Song R; Pei J; Huo Y; Li Y; Yang F; Cao W; Liu H; Liu X; Zheng H
    J Virol; 2022 Jun; 96(12):e0031722. PubMed ID: 35604142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esterase D enhances type I interferon signal transduction to suppress foot-and-mouth disease virus replication.
    Li W; Zhu Z; Cao W; Yang F; Zhang X; Li D; Zhang K; Li P; Mao R; Liu X; Zheng H
    Mol Immunol; 2016 Jul; 75():112-21. PubMed ID: 27267271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.